Interactions between metoclopramide and morphine: enhanced antinociception and motor dysfunction in rats

Area of Science:

• Pharmacology
• Neuroscience
• Pain Management

Background:

• Opioid analgesics and anti-emetics are frequently co-administered for managing pain and nausea in cancer patients.
• Understanding drug interactions is crucial for optimizing treatment and patient safety.

Purpose of the Study:

• To investigate the interaction between morphine and metoclopramide on pain perception (nociception) and motor function in rats.
• To determine if metoclopramide's anti-emetic effects, mediated by dopamine D2 and 5-HT3 receptor antagonism, influence morphine's analgesic properties.
• To assess the impact of morphine-metoclopramide co-administration on motor performance.

Main Methods:

• Rats received intraperitoneal injections of morphine and varying doses of metoclopramide or ondansetron.
• Nociception was assessed using the tail-flick test under basal and hyperalgesic conditions.
• Motor function was evaluated by measuring the ability of rats to maintain balance on a rotating rod.

Main Results:

• Metoclopramide alone did not exhibit analgesic or antihyperalgesic effects.
• The highest dose of metoclopramide significantly enhanced morphine's analgesic and antihyperalgesic effects.
• Ondansetron did not alter morphine's antinociceptive actions.
• Metoclopramide at a high dose impaired motor performance when given alone.
• Co-administration of morphine and metoclopramide significantly decreased motor performance.

Conclusions:

• Metoclopramide potentiates the analgesic and antihyperalgesic effects of morphine, likely through dopamine D2 receptor antagonism rather than 5-HT3 receptor antagonism.
• Morphine exacerbates metoclopramide-induced motor dysfunction.
• These findings suggest a complex interaction influencing both efficacy and safety when combining these agents.